Kalaris Therapeutics Inc

The current institutional shareholding score of Kalaris Therapeutics Inc is 7.00, ranking 80 out of 387 in the Biotechnology & Medical Research industry. The latest institutional shareholding proportion is 71.45%, representing a quarter-over-quarter decrease of 10.68%. The largest institutional shareholder is James Simons, holding a total of 0.00 shares, representing 0.29% of shares outstanding, with 4.32% increase in holdings.